ClariMedClariMed
Recherchen nahtlos fortsetzen
30 Sek mit Email - kein Passwort, kein Formular. Ihr Verlauf bleibt auf jedem Gerät.

Verlauf

Keine Anfragen

Cochrane2022IaEN

Cochrane Review: Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome

Zusammenfassung

Aromatasehemmer (Letrozol) zur Auslösung des Eisprungs bei subfertilen Frauen mit polyzystischem Ovar‐Syndrom - Franik, S - 2022 \| Cochrane Library [Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010287.pub4/full/de#main-content) [Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010287.pub4/full/de#) Cookies Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, includ

Kerninformationen

pub4/full/de#) [Cochrane Database of Systematic reviews](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention - [New search](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010287.pub4/information/de#history) Collapse all Expand all ## Abstract ava...
reatment clomiphene citrate (CC), a selective oestrogen receptor modulator (SERM). ### Objectives To evaluate the effectiveness and safety of AIs (letrozole) (with or without adjuncts) compared to SERMs (with or without adjuncts) for infertile women with anovulatory PCOS for ovulation induction fo...
nguage or publication status. ### Selection criteria We included all RCTs of AIs used alone or with other medical therapies for ovulation induction in women of reproductive age with anovulatory PCOS. ### Data collection and analysis Two review authors independently selected trials, extracted the...
Originaldokument ansehen

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen

Verwandte Leitlinien